Advantage Alpha Capital Partners LP Sells 216,143 Shares of Stevanato Group S.p.A. (NYSE:STVN)

Advantage Alpha Capital Partners LP decreased its position in Stevanato Group S.p.A. (NYSE:STVN) by 48.4% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 230,824 shares of the company’s stock after selling 216,143 shares during the period. Advantage Alpha Capital Partners LP’s holdings in Stevanato Group were worth $4,616,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Conestoga Capital Advisors LLC boosted its position in shares of Stevanato Group by 5.5% during the third quarter. Conestoga Capital Advisors LLC now owns 7,675,910 shares of the company’s stock valued at $153,518,000 after buying an additional 400,087 shares during the last quarter. Thrivent Financial for Lutherans boosted its holdings in shares of Stevanato Group by 67.6% during the 3rd quarter. Thrivent Financial for Lutherans now owns 2,784,912 shares of the company’s stock valued at $55,698,000 after acquiring an additional 1,123,104 shares during the last quarter. Pembroke Management LTD grew its stake in shares of Stevanato Group by 143.7% in the third quarter. Pembroke Management LTD now owns 1,051,140 shares of the company’s stock worth $21,023,000 after acquiring an additional 619,747 shares during the period. Fred Alger Management LLC grew its stake in shares of Stevanato Group by 7.6% in the second quarter. Fred Alger Management LLC now owns 861,727 shares of the company’s stock worth $15,804,000 after acquiring an additional 60,920 shares during the period. Finally, Thornburg Investment Management Inc. lifted its position in Stevanato Group by 279.1% during the second quarter. Thornburg Investment Management Inc. now owns 746,218 shares of the company’s stock valued at $13,690,000 after purchasing an additional 549,378 shares during the period.

Wall Street Analysts Forecast Growth

Separately, Citigroup decreased their target price on shares of Stevanato Group from $30.00 to $28.00 and set a “buy” rating for the company in a research note on Wednesday, August 7th.

Stevanato Group Price Performance

NYSE:STVN opened at €19.92 ($20.97) on Tuesday. Stevanato Group S.p.A. has a one year low of €16.56 ($17.43) and a one year high of €34.73 ($36.56). The business has a fifty day moving average price of €19.45 and a 200-day moving average price of €19.64. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.21 and a current ratio of 1.81.

Stevanato Group (NYSE:STVN) last posted its quarterly earnings data on Tuesday, November 5th. The company reported €0.12 ($0.13) EPS for the quarter, missing the consensus estimate of €0.13 ($0.14) by (€0.01) (($0.01)). The company had revenue of €277.90 million during the quarter, compared to the consensus estimate of €274.36 million. Stevanato Group had a return on equity of 9.86% and a net margin of 10.47%. The firm’s quarterly revenue was up 2.4% compared to the same quarter last year. During the same period last year, the business earned $0.16 EPS. Analysts anticipate that Stevanato Group S.p.A. will post 0.5 earnings per share for the current fiscal year.

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.